| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -3.2e-05 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -3.5e-05 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -9.6e-05 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |